4 Biotech Stocks Worthy Of Close Attention
When it comes to biotech’s performance over the last several weeks, the author of today’s article notes that “Part of the sector’s rise is undoubtedly… Read More »4 Biotech Stocks Worthy Of Close Attention
When it comes to biotech’s performance over the last several weeks, the author of today’s article notes that “Part of the sector’s rise is undoubtedly… Read More »4 Biotech Stocks Worthy Of Close Attention
When it comes to precious metals, the author of today’s article declares “I favor gold as a long-term investment, but when it comes to trading,… Read More »How To “Turbocharge” A Position In Volatile Silver
Shares of the commercial-stage biopharmaceutical company highlighted in today’s article have nearly doubled since mid-March. The biggest reason why? The debut of the company’s hot… Read More »The Reasons (Including One “Hidden Factor”) Why This Biopharmaceutical Stock Has Nearly Doubled Since Mid-March
As uncertain as things are right now, the author of today’s article advises that there are several categories of companies that will move higher in… Read More »Seeking Abnormal Returns In “The New Abnormal”
When it comes to the polarizing penny stock space, the author of today’s article acknowledges that the dilemma is the following: “How are investors supposed… Read More »Analysts Aren’t Polarized On These “Strong Buy” Healthcare Penny Stocks Offering “Outsized Upside Potential”
“A crucial aspect of success in investing in biotech stocks is that of timing,” notes the author of today’s article, who proceeds to examine one… Read More »Why Now May Be The Perfect Time To Buy This Biotech Stock – And Avoid This Other One
Despite the rejuvenated “risk-on” tone in the market at the moment, today’s article notes that traders are pricing in a lot of risk at one… Read More »Electoral Options: How – And Why – Traders Are Pricing In A Lot Of Risk In Early November
After a period of optimism amid calmer trading conditions, the S&P 500 just experienced its biggest plunge since March’s brutal selloff, as the Fed warned… Read More »Stock Pickers’ Summer Of Discontent?
When it comes to which of the two biotech stocks with COVID-19 vaccine candidates focused on in today’s article is the better pick going forward,… Read More »Better Pick A COVID-19 Vaccine Play